Naveen Pemmaraju: With MPN Guru and dear friend Prof Ruben Mesa at EHA2024

Naveen Pemmaraju recently shared a post on X:

“Wonderful to be here at EHA2024 with MPN Guru & dear friend Prof Ruben Mesa as we discussed novel drug combinations in Myelofibrosis & considerations of parameters for new response criteria in this new era of our Myeloproliferative Neoplasms (MPN) field!”

Source: Naveen Pemmaraju/X

Naveen Pemmaraju is a Professor and Director of the BPDCN Program at the Department of Leukemia at the University of Texas MD Anderson Cancer Center (MDACC) and Executive Director of the MDACC Network. He is also the Leukemia Hematology/Oncology Course Director.

His research work has been focused on improving outcomes and developing novel therapies for patients with rare, and ultra-rare, myeloid malignancies; including adolescents, young adults, and older adult patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), MPN and AML.